NCT06316882Completed
Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program
ROGCAS - Retrospective Observational Gastric Cancer Study
Source: ClinicalTrials.gov · Last updated 27 Feb 2025
Brief summary (registry, in English)
Endoscopic screening of gastric cancer combined with screening colonoscopy
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 349 (actual)
- First submitted
- 21 Nov 2023
- Start date
- 3 Feb 2023
- Primary completion date
- 24 Feb 2025
- Lead sponsor
- Unidade Local De Saúde Do Norte Alentejano
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06316882
What you commit to
- Study type: Observational
- Participants enrolled: 349
- From 3 Feb 2023 to the primary completion date, 24 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Exams without biopsies
Who the study is looking for
- people who agree to undergo endoscopic screening for gastric cancer;
- people who undergo screening colonoscopy
Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ULSNA Coordinator of this site? Confirm its status | Portalegre | Portugal | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.